Ncx3-Induced Mitochondrial Dysfunction in Midbrain Leads to Neuroinflammation in Striatum of A53t-α-Synuclein Transgenic Old Mice

Ncx3-Induced Mitochondrial Dysfunction in Midbrain Leads to Neuroinflammation in Striatum of A53t-α-Synuclein Transgenic Old Mice

The exact mechanism underlying selective dopaminergic neurodegeneration is not completely understood. The complex interplay among toxic alpha-synuclein aggregates, oxidative stress, altered intracellular Ca<sup>2+</sup>-homeostasis, mitochondrial dysfunction and disruption of mitochondri...

Full description

Bibliographic Details
Main Authors:	Rossana Di Martino, Maria Josè Sisalli, Rossana Sirabella, Salvatore Della Notte, Domenica Borzacchiello, Antonio Feliciello, Lucio Annunziato, Antonella Scorziello
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	International Journal of Molecular Sciences
Subjects:	Parkinson’s disease mitochondrial dysfunction neuroinflammation α-synuclein
Online Access:	https://www.mdpi.com/1422-0067/22/15/8177

Similar Items

Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells
by: Souvarish Sarkar, et al.
Published: (2020-01-01)

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
by: Maria Angela Samis Zella, et al.
Published: (2019-01-01)

Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson’s Disease
by: Antonella Cardinale, et al.
Published: (2021-06-01)

Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity
by: Matthew J. Benskey, et al.
Published: (2018-02-01)

Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
by: Changyoun Kim, et al.
Published: (2018-08-01)

Lymphocyte-activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-synuclein Spreading Pathology
by: Efthalia Angelopoulou, et al.
Published: (2020-04-01)

Immunoregulation of microglial polarization: an unrecognized physiological function of α-synuclein
by: Na Li, et al.
Published: (2020-09-01)

Papaverine inhibits α-synuclein aggregation by modulating neuroinflammation and matrix metalloproteinase-3 expression in the subacute MPTP/P mouse model of Parkinson’s disease
by: Yea-Hyun Leem, et al.
Published: (2020-10-01)

Hepcidin-to-Ferritin Ratio Is Decreased in Astrocytes With Extracellular Alpha-Synuclein and Iron Exposure
by: Juntao Cui, et al.
Published: (2020-03-01)

NCX1 and NCX3: Two new effectors of delayed preconditioning in brain ischemia
by: Giuseppe Pignataro, et al.
Published: (2012-01-01)

Extracellular Interactions of Alpha-Synuclein in Multiple System Atrophy
by: Dario Valdinocci, et al.
Published: (2018-12-01)

Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
by: Johan Wallin, et al.
Published: (2021-05-01)

Mitochondrial Homeostasis and Signaling in Parkinson’s Disease
by: Antonella Scorziello, et al.
Published: (2020-04-01)

Murine Models of Lysosomal Storage Diseases Exhibit Differences in Brain Protein Aggregation and Neuroinflammation
by: Jennifer Clarke, et al.
Published: (2021-04-01)

Developmental exposure to the organochlorine pesticide dieldrin causes male-specific exacerbation of α-synuclein-preformed fibril-induced toxicity and motor deficits
by: Aysegul O. Gezer, et al.
Published: (2020-07-01)

The Nigral Coup in Parkinson’s Disease by α-Synuclein and Its Associated Rebels
by: Jeswinder Sian-Hulsmann, et al.
Published: (2021-03-01)

Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies
by: Violetta Refolo, et al.
Published: (2019-06-01)

T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson’s disease
by: Meena S. Subbarayan, et al.
Published: (2020-08-01)

Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells
by: Francesca Garretti, et al.
Published: (2019-02-01)

FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis
by: Yu Ree Choi, et al.
Published: (2015-11-01)

Corynoxine Protects Dopaminergic Neurons Through Inducing Autophagy and Diminishing Neuroinflammation in Rotenone-Induced Animal Models of Parkinson’s Disease
by: Leilei Chen, et al.
Published: (2021-04-01)

α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson’s Disease Pathogenesis
by: Laura M. Butkovich, et al.
Published: (2018-09-01)

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
by: Yunna Li, et al.
Published: (2021-10-01)

CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
by: Yuanyuan Li, et al.
Published: (2019-12-01)

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
by: Georgia Minakaki, et al.
Published: (2020-12-01)

Knocking-out the Siah2 E3 ubiquitin ligase prevents mitochondrial NCX3 degradation, regulates mitochondrial fission and fusion, and restores mitochondrial function in hypoxic neurons
by: Maria Josè Sisalli, et al.
Published: (2020-03-01)

Corrigendum to “NCX1 and NCX3: Two new effectors of delayed preconditioning in brain ischemia” [Neurobiol. Dis. 45 (2012) 616–623]
by: Giuseppe Pignataro, et al.
Published: (2017-02-01)

Modeling Parkinson’s Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
by: Laura Boi, et al.
Published: (2020-11-01)

Motor neuron loss and neuroinflammation in a model of α-synuclein-induced neurodegeneration
by: Zachary A. Sorrentino, et al.
Published: (2018-12-01)

Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson’s disease: ex vivo and in vitro studies
by: Istvan Horvath, et al.
Published: (2018-06-01)

High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy
by: Antonio Heras-Garvin, et al.
Published: (2020-01-01)

Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates
by: Leonardo Acuña, et al.
Published: (2019-07-01)

The hypoxia sensitive metal transcription factor MTF-1 activates NCX1 brain promoter and participates in remote postconditioning neuroprotection in stroke
by: Valeria Valsecchi, et al.
Published: (2021-04-01)

Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils
by: Isabella Russo, et al.
Published: (2019-09-01)

Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons
by: M. Decressac, et al.
Published: (2012-03-01)

NCX1 is a new rest target gene: Role in cerebral ischemia
by: Luigi Formisano, et al.
Published: (2013-02-01)

The Role of Lipids in the Initiation of α-Synuclein Misfolding
by: Martin Kiechle, et al.
Published: (2020-09-01)

Neuroinflammation in Multiple System Atrophy: Response to and Cause of alpha-Synuclein Aggregation
by: Bruno eDi Marco Vieira, et al.
Published: (2015-11-01)

Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models
by: Michiyo Iba, et al.
Published: (2020-07-01)

Synuclein Family Members Prevent Membrane Damage by Counteracting α-Synuclein Aggregation
by: Christian Scheibe, et al.
Published: (2021-07-01)